Senator Investment Group LP Uni Qure N.V. Transaction History

Senator Investment Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$45.06 - $67.74 $18 Million - $27.1 Million	-400,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $3 Million - $5.55 Million	75,000 Added 23.08%	400,000 $19 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $12.1 Million - $24.3 Million	325,000 New	325,000 $23.3 Million
Q3 2019 Nov 13, 2019	SELL	$39.36 - $76.8 $18.7 Million - $36.5 Million	-475,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $25.1 Million - $39 Million	475,000 New	475,000 $37.1 Million

171

42.6M

2.61M

582K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $583M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.